Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Roberta DI BLASI"'
Autor:
Roberta Di Blasi, Steven Le Gouill, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Fabien Le Bras, François-Xavier Gros, Sylvain Choquet, Pierre Bories, Pierre Feugier, Olivier Casasnovas, Jacques Olivier Bay, Mohamad Mohty, Magalie Joris, Thomas Gastinne, Pierre Sesques, Jean-Jacques Tudesq, Laetitia Vercellino, Franck Morschhauser, Elodie Gat, Florence Broussais, Roch Houot, Catherine Thieblemont
Publikováno v:
Blood
Blood, 2022, 140 (24), pp.2584-2593. ⟨10.1182/blood.2022016945⟩
Blood, 2022, 140 (24), pp.2584-2593. ⟨10.1182/blood.2022016945⟩
Anti-CD19 chimeric antigen receptor (CAR) T-cells represent a major advance in the treatment of relapsed/refractory aggressive B-cell lymphomas. However, a significant number of patients experience failure. Among 550 patients registered in the French
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f52e802b137cf7c6a7b3707c88d4c12
https://univ-rennes.hal.science/hal-03903472/document
https://univ-rennes.hal.science/hal-03903472/document
Autor:
Raphaël Liévin, Roberta Di Blasi, Florence Morin, Eugenio Galli, Vincent Allain, Romain De Jorna, Laetitia Vercellino, Nathalie Parquet, Miryam Mebarki, Jerome Larghero, Eric de Kerviler, Isabelle Madelaine, Sophie Caillat-Zucman, Sylvie Chevret, Catherine Thieblemont
Publikováno v:
Bone Marrow Transplantation
Bone Marrow Transplantation, 2022, 57 (3), pp.431-439. ⟨10.1038/s41409-021-01526-0⟩
Bone Marrow Transplantation, 2022, 57 (3), pp.431-439. ⟨10.1038/s41409-021-01526-0⟩
Chimeric Antigen Receptor T cells (CAR-T) are an outbreaking treatment option for relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). Cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3cc58121d48c3753b490c6d362532b6
https://www.hal.inserm.fr/inserm-03924924
https://www.hal.inserm.fr/inserm-03924924
Autor:
Dorine de Jong, Laetitia Vercellino, Salim Kanoun, Lawrence H. Schwartz, Roberta Di Blasi, Laurent Dercle, Ran Reshef
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, 2021, 11 (16), pp.3998. ⟨10.3389/fonc.2021.664688⟩
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, 2021, 11 (16), pp.3998. ⟨10.3389/fonc.2021.664688⟩
Frontiers in Oncology, Vol 11 (2021)
International audience; Chimeric antigen receptor (CAR) T-cells are a novel immunotherapy available for patients with refractory/relapsed non-Hodgkin lymphoma. In this indication, clinical trials have demonstrated that CAR T-cells achieve high rates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76c0cf9944a5a75953310c3351b0d161
https://www.hal.inserm.fr/inserm-03925068/file/fonc-11-664688.pdf
https://www.hal.inserm.fr/inserm-03925068/file/fonc-11-664688.pdf
Autor:
Agusti Alentorn, Franck Bielle, Valérie Pourcher, Caroline Houillier, Nadine Martin-Duverneuil, Basma Abdi, Renata Ursu, Fernando Lozano, Ahmed Idbaih, Bertrand Mathon, Mehdi Touat, Alice Laurenge, Lila Sirven-Villaros, Anne-Geneviève Marcelin, Jean Yves Delattre, Karima Mokhtari, Khê Hoang-Xuan, Gianpiero Tebano, Sylvain Choquet, Antoine F. Carpentier, Cyril Quemeneur, Alberto Duran-Peña, Andrea Morales, Roberta Di Blasi, Véronique Leblond
Publikováno v:
Journal of Neurology
Journal of Neurology, Springer Verlag, 2021, ⟨10.1007/s00415-020-10311-w⟩
Journal of Neurology, 2021, ⟨10.1007/s00415-020-10311-w⟩
Journal of Neurology, Springer Verlag, 2021, ⟨10.1007/s00415-020-10311-w⟩
Journal of Neurology, 2021, ⟨10.1007/s00415-020-10311-w⟩
Background Cancer patients may be at higher risk for severe coronavirus infectious disease-19 (COVID-19); however, the outcome of Primary Central Nervous System Lymphoma (PCNSL) patients with SARS-CoV-2 infection has not been described yet. Methods W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c735eec2654571d47a06c562556f02e
https://hal.sorbonne-universite.fr/hal-03146856/file/Laurenge2021_Article_SARS-CoV-2InfectionInPatientsW.pdf
https://hal.sorbonne-universite.fr/hal-03146856/file/Laurenge2021_Article_SARS-CoV-2InfectionInPatientsW.pdf